TLSA Tiziana Life Sciences Ltd
Healthcare$1.51+2.03%ClosedMarket Cap: $89.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.36
P/S
0.00
EV/EBITDA
2.33
DCF Value
$0.17
FCF Yield
—
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-125.8%
ROA
-37.0%
ROIC
-41.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | -Infinity% | $-12.3M | $-12.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-21.3M | $-18.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-9.0M | $-5.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-9.2M | $-7.2M | $— | — |
| FY null | $0.00 | NaN% | $-15.8M | $-11.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-12.9M | $-9.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.2M | $-9.1M | $— | — |
| FY null | $0.00 | NaN% | $-18.0M | $-17.7M | $— | — |
| Q2 null | $0.00 | Infinity% | $-11.8M | $-8.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-10.0M | $-10.9M | $— | — |
| FY null | $0.00 | NaN% | $-14.6M | $-15.4M | $— | — |
| Q2 null | $0.00 | Infinity% | $-4.5M | $-4.5M | $— | — |